Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 534 results for "zydus cadila"

Cadila Healthcare recalls blood pressure drug in the US
Financial Express

Cadila Healthcare recalls blood pressure drug in the US

The recall of the 5,400 bottles has been voluntarily initiated by the company through its US based arm Zydus Pharmaceuticals USA Inc. WASHINGTON: Drug firm Cadila Healthcare is voluntarily recalling 5,400 bottles of anti-hypertension drug Atenolol tablets, in ... Economic Times, 1 month ago
Cadila Healthcare recalls anti-hypertension drug in US Hindu Business Line, 1 month ago
Cadila recalls drug in US Calcutta Telegraph, 1 month ago

3 images for "zydus cadila"

Sify, 2 weeks ago
Business Standard, 2 weeks ago
Outlook, 1 month ago
India TV

Zydus gets USFDA nod to market anti-diabetic tablets; closes down 1.15%

Cadila Healthcare closed today at 1.15% at Rs. 1,272 on BSE. The stock opened at Rs. 1,300 and closed at Rs. 1,272. The stock hit a high of Rs. 1323 and a low of Rs. 1,262. Zydus Cadila has received tentative approval from the USFDA to market ...
 India Infoline2 months ago Cadila Health up 3%, diabetic drug gets tentative USFDA nod  Money Control2 months ago Zydus gets USFDA tentative nod for diabetic tablets  Press Trust of India2 months ago Zydus gets tentative nod for Glipizide ER tablets  MyIris2 months ago

Zydus Cadila's Net Profit up by 52% in Q2

You currently are not registered for any FirstWord Pharma services. Register to FirstWord Pharma for free access to 10 articles every 30 days: You can also: Wait 12 days for your content allowance to be renewed. Sign up for a free trial to ...
 FirstWord Pharma2 weeks ago Cadila Healthcare Q2 net up 52% at Rs 278 crore  The Financial Chronicle2 weeks ago Zydus Cadila Q2 net up 52% at Rs 278 cr  Sify2 weeks ago Cadila Healthcare Q2 Net Rises 52%  NDTV Profit2 weeks ago
Business Standard

Alembic to commission Sikkim plant this fiscal

Companies like Intas Pharma, Torrent Pharma, Zydus Cadila etc already have facilities in Sikkim Sohini Das | Ahmedabad November 2, 2014 Last Updated at 20:58 IST Vadodara-based pharma company Alembic Pharmaceuticals is all set to commission its formulations ...
 Business Standard3 weeks ago

Trigger Happy

Zydus Cadila COO and executive director Ganesh Nayak on how skeet shooting helps him keep his eyes trained on business goals Growing up in Bombay, Ganesh Nayak spent all his free time reading the iconic Phantom comic series, fascinated by the Lee Falk-created ...
 Outlook1 month ago
Business Standard India

Zydus plans to have 15 biologic products in two years

With an eye on the growing biologics market, Ahmedabad-based pharma major Cadila Healthcare (Zydus Cadila) is planning to mark its presence in the segment. The company plans to launch one to three products by next year, and hopes to have a portfolio ...
 Business Standard India1 month ago Zydus Cadila bags license for hepatitis C drug  Business Standard2 months ago

Zydus Cadila gets tentative approval from US FDA for Glipizide ER tablets

Zydus Cadila has received tentative approval from the US FDA (Food and Drug Administration) to market Glipizide Extended-release (ER) tablets in the strengths of 2.5 mg, 5 mg, and 10 mg. The drug falls in the ant-diabetic segment. The estimated ...
 Indian-Commodity2 months ago Cadila Healthcar - Zydus receives tentative approval for Gli...  SBICAP Securities2 months ago India : TENTATIVE Approval for Glipizide ER Tablets received by Zydus [TendersInfo (India)]  Pharmacy Choice2 months ago Zydus receives tentative approval for Glipizide ER tablets  Money Control2 months ago

Zydus Cadila sets Rs 10,000 cr sales target by FY16

Homegrown drug major Zydus Cadila has set a target of clocking a consolidated turnover of over Rs 10,000 crore by FY'16. "We will have a revenue of Rs 10,000 crore in FY16. We closed last fiscal with a revenue of Rs 7,208 crore," Zydus Cadila Chief ...
 Business Standard2 months ago Zydus Cadila sets Rs 10,000 crore sales target by FY16  Economic Times2 months ago

Supernus Files Trokendi XR Patent Infringement Lawsuit

Supernus Pharmaceuticals, Inc. ( SUPN ) has filed a patent infringement lawsuit against Zydus Pharmaceuticals ( USA ) Inc. and Cadila Healthcare Limited accusing them of infringement of three patents covering Supernus antiepileptic drug, Trokendi ...
 Yahoo! Finance1 day ago

Supernus files lawsuit against Zydus in US court for infringement of patents covering its antiepileptic drug, Trokendi XR

Supernus Pharmaceuticals, a specialty pharmaceutical company focused on developing and commercializing products for the treatment of CNS disease, sannounced that it sued generic drug makers Zydus Pharmaceuticals (USA) Inc. and Cadila Healthcare ...
 PharmaBiz2 days ago Supernus Pharmaceuticals Files Lawsuit Against Zydus Pharmaceuticals (USA) Inc. In U.S. Court For Infringement Of Patents Covering Its Antiepileptic Drug, Trokendi XR  BioSpace21 hours ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - zydus cadila
Get updated on latest news & your favorite topics right in your inbox!
More     Less